A Popular Cancer Target Is Eyed for a Rare Immune Disorder

Anurag Relan, chief medical officer of Pharming, discusses the rare immune condition APDS, the role PI3K inhibitors can play in treating it, and why a potential drug in development to treat the condition may have broader use in autoimmune and inflammatory diseases.